Reuters logo
4 个月前
BRIEF-CTI Biopharma announces license and agreement expansion with Servier to commercialize Pixuvri
2017年4月25日 / 凌晨5点46分 / 4 个月前

BRIEF-CTI Biopharma announces license and agreement expansion with Servier to commercialize Pixuvri

April 25 (Reuters) - Cti Biopharma Corp:

* Servier and CTI biopharma expand license and collaboration agreement to develop and commercialize Pixuvri

* Servier will commercialize Pixuvri in all markets except the US

* Will retain rights to commercialize Pixuvri in the US

* Servier will pay Co 12 million euros ($13.0 million) with potential for Co to receive eur 76 million in additional sales and regulatory milestone payments as well as royalties on net product sales Source text for Eikon: Further company coverage: ($1 = 0.9201 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below